TOP STORIES
Valeant Pharmaceuticals CEO Michael Pearson went from one hospital to another after getting diagnosed with “severe” pneumonia and is still hospitalized. The company said on Christmas Day he had entered the hospital. While he checked out of one facility on Sunday the company said he remained at another. – Bloomberg
LIFE SCIENCES
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Rich Pharmaceuticals will move forward with trials of its treatments for Acute Myelocytic Leukemia and Myelodysplastic Syndrome. – PR Newswire
Here’s how smell tests will become true tests for neurodegenerative diseases. – Scientific American
PAYERS-PROVIDERS
Good number or bad number? “46 percent of consumers with a chronic condition who were surveyed said they discovered their illness through a wellness program.” – PR Newswire
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A closer look at what hospitals get out of the 21st Century Cures Act. – MedPage Today
TECHNOLOGY
The corporate venture arm of a Japanese ad agency has invested in the San Diego health-tracking company Cue. – The Bridge
One theory about the spread of the cloud: A report from one venture fund suggests “the adoption of cloud technologies is lagging in the rest of the world.” – Business Insider
POLITICS
Here’s the deep dive into Obamacare 2016 you haven’t been asking for. – The Hill
A LITTLE BIT EXTRA
A new poll of American shows 40 percent think terrorists are winning against the United States – 17 points higher than the previous high. – CNN
Photo: Flickr user Kevin Dooley
